Riskpilot← Back to searchSign inGet full accessKALI HUD- OG HELSETERAPI AS
ASActiveOrg 993961469Øyro 35, 5200 OsOther human health activities n.e.c. · NACE 8699Est. 20095 employees
Revenue 2025
NOK 1,8M
+8% vs 2024
EBITDA margin
-2.1%
+77% vs 2024
Equity ratio
-401.1%
Financial strength
Net profit 2025
NOK -39K
+77% vs 2024
| Revenue | NOK 1,8M | +8% |
| EBITDA | NOK -38K | +77% |
| Net profit | NOK -39K | +77% |
| Total assets | NOK 283K | +22% |
| Equity | NOK -1,1M | -4% |
| Employees | 5 | — |
Legal name
KALI HUD- OG HELSETERAPI AS
Org number
993961469
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
15. april 2009
Share capital
NOK 100 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder og nestleder hver for seg.
Company purpose
Yte naturterapi- og helsetjenester, og salg av produkter som naturlig hører sammen med dette, samt investering i andre virksomheter som driver med dette.
Address
Øyro 35, 5200 Os
Phone
+4756301733
Email
kali@kali.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 107 | 1 961 | 1 743 | 1 651 | 1 778 |
| Staff expenses | −1 252 | −1 286 | −1 145 | −1 184 | −1 185 |
| EBITDA | 121 | −43 | −111 | −167 | −38 |
| Depreciation & amort. | −1 | −3 | −3 | −3 | −3 |
| EBIT | 120 | −47 | −114 | −170 | −41 |
| Net financials | 2 | 2 | 2 | 2 | 3 |
| Profit before tax | 122 | −45 | −112 | −168 | −39 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 122 | −45 | −112 | −168 | −39 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 341 | 279 | 198 | 232 | 283 |
| Equity | −773 | −818 | −930 | −1 098 | −1 137 |
| Long-term debt | 243 | 279 | 675 | 848 | 1 020 |
| Short-term debt | 871 | 818 | 454 | 482 | 400 |
| Total debt | 1 114 | 1 097 | 1 129 | 1 330 | 1 420 |
EBITDA margin
-2.1%
This company
15.8%
Market median
-113% vs market
20212025
Equity ratio
-401.1%
This company
38.2%
Market median
-1150% vs market
20212025
Return on equity
-3884900.0%
This company
18.4%
Market median
-21113687% vs market
20212025
Net profit margin
-2.2%
This company
8.1%
Market median
-127% vs market
20212025
Asset turnover
6.27×
This company
1.12×
Market median
+460% vs market
20212025
Debt / equity
1.25×
This company
0.62×
Market median
-102% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KH Chief Executive Officer | Chief Executive Officer | 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2019 | |
| Board of Directors | 2019 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of KALI HUD- OG HELSETERAPI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karlotte Halldis Møgster | Chief Executive Officer | 0 companies |
| Elin Espevik Andreassen | Board of Directors | 0 companies |
| Bjørn Arve Lepsøy | Board of Directors | 0 companies |